Comprehensively taking into account the function of YB-1 phosphorylation in promoting DSB repair and driving cell cycle G1/S phase transition, we hypothesize that YB-1 phosphorylation may remove the blocking effect of CDK4/6i on G1/S phase transition and lead to the occurrence of CDK4/6i resistance in breast cancer. Here, CDK4 is linked to breast cancer.